- Heart Transplant
-
- A facilitated access program to provide everolimus (RAD) for maintenance patients completing therapy in RAD trials in solid organ transplantation
-
- Investigator: Lee Goldberg, MD
- A six-month, multicenter, randomized, open full label study of the safety, tolerability and efficacy of two neoral doses in addition to cerican and steroids in de novo heart transplant recipients
-
- Investigator: Lee Goldberg, MD
- A pilot study of cardiothoracic (CT) coronary angiography for the detection of transplant arteriopathy
-
- Investigator: Susan Brozena, MD
- Human heart tissue protocol
-
- Investigator: Kenneth Margulies, MD
- Sponsored by: National Institutes of Health (NIH)
- Kidney Transplant
- One-year exploratory study to evaluate the efficacy and safety of belimumab for normalization of alloantibody levels in sensitized patients awaiting kidney transplantation.
-
- Investigator: Ali Naji, MD, PhD
- Changes in skeletal microarchitecture following renal transplantation
-
- Investigators: Simin Goral, MD and Mary Leonard, MD
- Genetic determinants of kidney transplant outcomes
-
- Investigator: Sylvia E. Rosas, MD
- Sponsored by: National Institutes of Health
- Vascular calcification in kidney transplant recipients
-
- Investigator: Sylvia E. Rosas, MD
- Sponsored by: American Heart Association
- Clinical trials in organ transplantation (CTOT)
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- A phase IV, randomized, open-label, comparative, single-center study to assess gastrointestinal adverse event outcomes of de novo African American kidney transplant recipients treated with Prograf® (tacrolimus) /CellCept® (mycophenolate mofetil)/corticosteroids versus Prograf (tacrolimus)/Myfortic® (enteric-coated mycophenolate sodium)/corticosteroids
-
- Investigator: Roy Bloom, MD
- Liver Transplant
- Genes related to HCC progression in liver transplant recipients
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: NIH/NIDDK
- Molecular profiling and donor and recipient pro inflammatory and alloimmune response
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- Tissue and serum bank
-
- Investigator: Kim Olthoff, MD
- Gene expression and regenerative pathways in donor livers
-
- Investigator: Kim Olthoff, MD
- Sponsored by: National Institutes of Health
- A phase II trial to assess the safety of immunosuppression withdrawal in liver transplant recipients with hepatitis C
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: Immune Tolerance Network
- Validation of serum markers for the early detection of hepatocellular carcinoma (DCP)
-
- Investigator: K. Rajender Reddy, MD
- Sponsored by: National Cancer Institute
- A2 ALL: adult-to-adult living donor liver transplant cohort study)
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- A2 ALL: adult-to-adult living donor liver transplant cohort study)
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- Clinical, immunologic and pharmacologic consequences of liver transplantation in people with HIV infection
-
- Investigator: Kim Olthoff, MD
- Sponsored by: National Institutes of Health
- Comparative evaluation of inhibitor treatments in liver allograft recipients
-
- Investigator: K. Rajender Reddy, MD
- Comparative safety and efficacy study of prophylactic interferon following liver transplantation for hepatitis C
-
- Investigator: K. Rajender Reddy, MD
- Sponsored by: National Institutes of Health
- Safety and efficacy study of N-acetylcysteine in the treatment of acute liver failure not caused by acetaminophen in adult patients
-
- Investigator: K. Rajender Reddy, MD
- Sponsored by: National Institutes of Health
- An observational database of patients who receive orthotopic liver transplantation (OLT) for hepatitis B
-
- Investigator: K. Rajender Reddy, MD
- Comparison of HepeX-BTM, a mixture of two monoclonal antibodies, to hepatitis B immune globulin in patients who have received hepatic allografts for treatment of end-stage liver disease due to hepatitis B virus infection
-
- Investigator: K. Rajender Reddy, MD
- Intravenous terlipressin in patients with hepatorenal syndrome type I
-
- Investigator: K. Rajender Reddy, MD
- Lung Transplant
- Dietary Antioxidant Therapy in Patients Awaiting Lung Transplantation
-
- Investigator: James Lee, MD
- Clinical Risk Factors of Primary Graft Failure, a Multicenter Study
-
- Investigator: Jason D. Christie, MD
- Genetics of Primary Graft Failure, a Multicenter Study
-
- Investigator: Jason D. Christie, MD
- Clinical Trials in Organ Transplantation
-
- Investigator: Jason D. Christie, MD
- The HLA Antibodies after Lung Transplantation (HALT) Study
-
- Investigator: Vivek N. Ahya, MD
Advanced Lung Disease Research Studies
Bronchiectasis
- A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Repeated Courses of Aztreonam for Inhalation Solution in Subjects with non-CF Bronchiectasis and Gram-Negative Endobronchial Infection (AIR-BX1), Gilead
-
- Investigator: Gregory Tino, MD
- A Consolidated Database of Non-Cystic Fibrosis Bronchiectasis Patients from Major Clinical and Research Institutions (NON-TREATMENT)
-
- Investigator: Gregory Tino, MD
IPF
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis, InterMune (TREATMENT)
-
- Investigator: Gregory Tino, MD
- NAC vs. Placebo, PANTHER – IPFNet trial (TREATMENT)
-
- Investigator: Milton Rossman, MD
- A 52 weeks, double blind, randomized, placebo-controlled trial evaluating the effect of oral BIBF 1120, 150 mg twice daily, on annual Forced Vital Capacity decline, in patients with Idiopathic Pulmonary Fibrosis (TREATMENT)
-
- Investigator: Milton Rossman, MD
- PA-IPF Registry(NON-TREATMENT)
-
- Investigator: Milton Rossman, MD
- Pancreas and Islet Cell Transplant
- Islet transplantation in type 1 diabetes using immunosuppression and strategies to improve long term graft survival
-
- Investigator: Ali Naji, MD, PhD
- Sponsored by: National Institutes of Health
- Using anti-B lymphocyte agent rituximab (Rituxan) to improve long-term graft survival
-
- Investigator: Ali Naji, MD, PhD
- Sponsored by: National Institutes of Health
- Islet transplantation vs. intensive insulin therapy in patients with type 1 diabetes who have already received a kidney transplant
-
- Investigator: Ali Naji, MD, PhD
- Sponsored by: National Institutes of Health
